Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. (Q48432831)
Jump to navigation
Jump to search
scientific article published in October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. |
scientific article published in October 2013 |
Statements
1 reference
Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. (English)
1 reference
Arif Khan
1 reference
James Faucett
1 reference
Shaneta Morrison
1 reference
Walter A Brown
1 reference
1 October 2013
1 reference
1 reference
70
1 reference
1091-1099
1 reference
10
1 reference
Identifiers
1 reference
1 reference